+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 3Years - 16Years
All Genders
ID07815249

Motor Speech Therapy Study for Children with Childhood Apraxia of Speech and Rare Genetic Conditions Using Single Case Experimental Design

Led by Murdoch Childrens Research Institute · Updated on 2026-09-11

20

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether speech therapy can improve speech accuracy in children aged 3 to 16 years who have childhood apraxia of speech CAS and rare genetic conditions. This study uses a single case experimental design to assess each child individually, focusing on how two specific motor speech therapy approaches affect speech accuracy and communication. The trial aims to understand the effects of these therapies on trained and untrained speech targets, speech intelligibility, and functional communication. Participants will receive one of two types of motor speech therapy Rapid Syllable Transition Treatment ReST or Dynamic Temporal and Tactile Cueing DTTC. Each child is assigned to one treatment based on age and speech ability. Therapy consists of 60-minute sessions three times a week over four weeks, totaling 12 sessions. Before treatment, participants undergo baseline speech assessments twice weekly for 1.5 to 2.5 weeks. After treatment, follow-up assessments occur at 1, 4, and 8 weeks to measure maintenance of progress. During the study, participants complete speech assessments repeatedly before, during, and after therapy to track changes in speech accuracy, intelligibility, and vocal control. Parents provide feedback on communication and quality of life. Speech sessions are monitored for quality, and adherence is supported by individualized speech targets. The total duration for each participant is about four months, including baseline, treatment, and follow-up phases, with ongoing evaluation of speech outcomes and therapy tolerability.

CONDITIONS

Brief Title

Speech Therapy for Children With Rare Genetic Conditions and Childhood Apraxia of Speech

Research Team

M

Miya D St John, PhD

M

Maddy K Hill, MSpPath

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here